Abbott Biotechnology competitive analysis

Explore Abbott Biotechnology's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Nov 2, 2016Multiple-Variable Dose Regimen For Treating Tnfalpha-Related Disorders11
Mar 11, 2015Treatment Of Tnf Alpha Related Disorders13
Jan 14, 2015Method Of Treating Depression Using A Tnf-Alpha Antibody2

Latest PTAB cases involving Abbott Biotechnology

Discover the latest PTAB cases involving Abbott Biotechnology, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Abbott Biotechnology with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ABBOTT BIOTECHNOLOGY - 26 - -
AMGEN14168811
BREUER20 - - -
HOFFMANN EITLE191 - - -